Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 18/20 | 0.55 |
| ▸ | CA1 | P00915 | 17/20 | 0.55 |
| ▸ | MMP1 | P03956 | 6/20 | 0.55 |
| ▸ | MMP2 | P08253 | 6/20 | 0.55 |
| ▸ | MMP9 | P14780 | 6/20 | 0.55 |
| ▸ | MMP8 | P22894 | 6/20 | 0.55 |
| ▸ | MMP13 | P45452 | 6/20 | 0.55 |
| ▸ | F2 | P00734 | 2/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.38 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.38 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9069079 | 0.98 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL9069077 | 0.98 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL9068574 | 0.98 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL9068883 | 0.98 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| Sulfluramid SCHEMBL26873 | 0.98 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| Sulfluramid SCHEMBL2316089 | 0.96 | CA2 (0.53) | CA2CA1MMP1MMP2MMP9 | |
| Sulfluramid SCHEMBL28666475 | 0.96 | CA2 (0.53) | CA2CA1MMP1MMP2MMP9 | |
| SCHEMBL19042178 | 0.93 | CA2 (0.47) | CA2CA1MMP1MMP2MMP9 | |
| Sulfluramid SCHEMBL9101246 | 0.92 | CA2 (0.55) | CA2CA1MMP1MMP2MMP9 | |
| Sulfluramid SCHEMBL28312518 | 0.89 | CA2 (0.54) | CA2CA1MMP1MMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12583764-B2 | PFAS treatment process for liquid effluent | SUEZ INTERNATIONAL (FR) | 2026-03-24 | — | — | US | disclosed |
| EP-4185555-B1 | PFAS TREATMENT PROCESS FOR LIQUID EFFLUENT | SUEZ INT (FR) | 2025-10-01 | — | — | EP | disclosed |
| US-20230348295-A1 | PFAS TREATMENT PROCESS FOR LIQUID EFFLUENT | SUEZ INTERNATIONAL (FR) | 2023-11-02 | — | — | US | disclosed |
| US-20170184962-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170184964-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170184963-A1 | RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| EP-0599023-B1 | Fluorochemical aminoalcohols | MINNESOTA MINING & MFG (US) | 2000-08-16 | — | — | EP | disclosed |
| US-5539024-A | REACTION PRODUCT OF PERFLUOROALKYL SULFONAMIDE, OXYETHYLENE COMPOUND SUCH AS POLYETHERESTER, AND EPOXY COMPOUND SUCH AS NOVOLAC GLYCIDYL ETHER, PROTECTIVE COATINGS FOR PAPER, TEXTILES, LEATHER, MINERALS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-07-23 | — | — | US | disclosed |
| US-5380778-A | Fluoroamino alcohol, thermoplastic resin, oil and water repellant coating for carpet fibers | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-01-10 | — | — | US | disclosed |
| EP-0599023-A2 | Fluorochemical aminoalcohols | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-06-01 | — | — | EP | disclosed |
| US-4293441-A | FLUOROALIPHATICSULFONAMIDO PHOSPHONIC ACID, ETHYLENE GLYCOL OR PROPYLENE GLYCOL | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-10-06 | — | — | US | disclosed |
| US-4202706-A | Corrosion resistance treatment of aluminum with N-alkyl-fluoroaliphaticsulfonamidophosphonic acids and salts thereof | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1980-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583764-B2 | PFAS treatment process for liquid effluent | PFAS, FGB, FGR | CA2 1644/4885CA1 1497/4885MMP1 3259/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.